Verici Dx (LON:VRCI) Shares Down 8.6% – Here’s What Happened

Verici Dx plc (LON:VRCI)’s share price was down 8.6% on Wednesday . The company traded as low as GBX 0.45 and last traded at GBX 0.48. Approximately 2,220,681 shares changed hands during trading, an increase of 50% from the average daily volume of 1,484,795 shares. The stock had previously closed at GBX 0.53.

Verici Dx Stock Performance

The firm has a market capitalization of £7.26 million, a price-to-earnings ratio of -0.17 and a beta of 1.52. The firm has a 50 day moving average price of GBX 0.61 and a 200-day moving average price of GBX 0.70. The company has a debt-to-equity ratio of 11.36, a current ratio of 0.91 and a quick ratio of 8.49.

About Verici Dx

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.